Can-Fite BioPharma Ltd. (CANF)
NYSEAMERICAN: CANF · Real-Time Price · USD
4.350
+0.040 (0.93%)
Feb 19, 2026, 12:20 PM EST - Market open
Can-Fite BioPharma Market Cap
Can-Fite BioPharma has a market cap or net worth of $5.67 million as of February 19, 2026. Its market cap has decreased by -63.27% in one year.
Market Cap
5.67M
Enterprise Value
-1.19M
1-Year Change
-63.27%
Ranking
Category
Stock Price
$4.35
Market Cap Chart
Since November 3, 2008, Can-Fite BioPharma's market cap has decreased from $18.49M to $5.67M, a decrease of -69.36%. That is a compound annual growth rate of -6.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 18, 2026 | 5.90M | -76.05% |
| Dec 31, 2025 | 24.64M | 58.34% |
| Dec 31, 2024 | 15.56M | 75.98% |
| Dec 31, 2023 | 8.84M | -54.56% |
| Dec 29, 2022 | 19.46M | -49.59% |
| Dec 30, 2021 | 38.60M | 34.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Theriva Biologics | 6.49M |
| Creative Medical Technology Holdings | 6.40M |
| Mustang Bio | 6.38M |
| Aptorum Group | 6.37M |
| Moolec Science | 6.27M |
| Alzamend Neuro | 6.20M |
| Purple Biotech | 6.01M |
| Alaunos Therapeutics | 5.74M |